Can adults who were infected with HSV‑1 in childhood develop oral lesions later in life and transmit the virus to a sexual partner?

Can Adults with Childhood HSV-1 Develop Oral Lesions and Transmit to Partners?

Yes—adults who acquired HSV-1 in childhood can develop recurrent oral lesions throughout their lifetime and transmit the virus to sexual partners through both oral-to-oral and oral-to-genital contact, even during asymptomatic periods.

Natural History of HSV-1 Infection

Primary Infection and Latency

• HSV-1 is typically acquired during childhood through non-sexual contact, causing either asymptomatic infection or acute gingivostomatitis. 1
• After primary infection resolves, the virus establishes lifelong latency in the cervical (trigeminal) ganglia, where it persists in a dormant state. 1
• The virus can reactivate at any point throughout adult life, producing recurrent oral lesions (herpes labialis or "cold sores"). 1, 2

Recurrence Patterns

• Recurrent episodes arise from viral reactivation in the ganglia, not from new exposure. 1
• Reactivation triggers include ultraviolet light exposure, fever, psychological stress, menstruation, and upper respiratory infections. 2
• Recurrence frequency varies widely—from once every few years to several times per month—and typically decreases over time. 1

Viral Shedding and Transmission Risk

Symptomatic Shedding

• Peak viral titers occur within the first 24 hours after lesion onset, when most lesions are vesicular. 2
• Viral shedding is highest when herpetic lesions (oral or genital) are visibly present. 3
• The CDC recommends avoiding all sexual contact when orolabial lesions are evident. 3

Asymptomatic Shedding

• HSV-1 reactivation on oral mucosa is common and usually asymptomatic, with widespread shedding throughout the oral cavity. 4
• In one study of HSV-1 seropositive adults, oral HSV-1 was detected on 26.5% of days, with 27.1% of shedding occurring on days without lesions or symptoms. 4
• Asymptomatic viral shedding can occur on average 28% of days when measured by sensitive PCR testing. 5
• Most transmissions to sexual partners occur during asymptomatic viral shedding. 5, 6

Transmission to Sexual Partners

Oral-to-Oral Transmission

• Direct contact with infected oral secretions or lesions transmits HSV-1 to the partner's oral mucosa. 5, 7
• Frequent oral shedding of HSV-1 increases the risk of transmitting the virus to both oral and genital mucosa of sexual partners. 4

Oral-to-Genital Transmission

• HSV-1 now accounts for approximately half of new genital herpes cases in developed countries, primarily through orogenital sexual practices. 1, 8, 6
• In young women with primary genital infection, HSV-1 is much more frequent than HSV-2 (84% HSV-1 in one Swedish study). 9
• There is a significant correlation between having orogenital sex and being infected with genital HSV-1, as well as a history of labial herpes in the partner. 9
• The proportion of HSV-1 detection in genital herpes is increasing by 1.02-fold per year in the United States. 10

Clinical Implications and Counseling

Risk Communication

• All patients with oral HSV-1 must be counseled that sexual transmission can occur during asymptomatic periods. 11
• Counseling should emphasize:
  • Potential for transmission even without visible lesions or symptoms 11
  • Need to disclose HSV status to sexual partners 11
  • Risk of transmitting HSV-1 to a partner's genital area through oral sex 1, 9

Prevention Strategies

• The CDC recommends using latex condoms during every act of sexual intercourse to reduce HSV exposure risk. 3, 11
• Abstain from sexual contact (including oral sex) whenever orolabial lesions or prodromal symptoms are present. 3, 11
• Partners should be counseled about transmission risks and urged to seek evaluation if symptoms develop. 12

Suppressive Therapy Considerations

• Daily suppressive antiviral therapy (acyclovir, famciclovir, or valacyclovir) reduces—but does not eliminate—asymptomatic shedding. 11
• Suppressive therapy is typically reserved for patients with frequent or severe recurrences (≥6 episodes per year). 3, 12
• For oral herpes labialis, episodic treatment at the first prodromal sign is the standard approach, rather than continuous suppression. 2

Common Pitfalls

• Do not assume that absence of visible oral lesions means no transmission risk—asymptomatic shedding accounts for the majority of HSV-1 transmission events. 4, 5
• Do not overlook the increasing role of HSV-1 in genital herpes—clinicians should type all genital herpes isolates, as HSV-1 and HSV-2 have different recurrence patterns (HSV-1 genital infections recur less frequently). 1, 8
• Do not fail to educate patients that childhood oral HSV-1 infection is lifelong and can reactivate at any age, with potential for sexual transmission throughout adulthood. 1, 7